Abstract
We have reported that β‐catenin‐accumulated crypts (BCAC), which do not have the appearance of aberrant crypt foci (ACF) are possible colonic premalignant lesions in rats. Suppression of the occurrence and advancement of such lesions should have critical relevance to cancer prevention. This study examined whether sulindac, a chemopreventive nonsteroidal anti‐inflammatory drug is able to induce apoptosis in such premalignant lesions. At 6 weeks of age, rats groups 1–3 were given azoxymethane (AOM) (15 mg/kg‐body weight) once weekly for 3 weeks. Two groups were given sulindac in the diet (200 and 400 ppm), starting at 9 weeks of age. The rats were sacrificed at the termination, and the colons were carefully examined. The incidence and crypt multiplicity of BCAC and ACF were significantly less than those of the control group. The effect of sulindac on the expression of BCAC was greater than that on ACF. Exposure to sulindac significantly increased the apoptotic index (terminal deoxynucleotide transferase dUTP nick‐end labeling (TUNEL)‐positive cells) in BCAC. However, no significant increase of the index was found in the case of ACF. These results suggest that the chemopreventive effect of sulindac in rats is related to the induction of apoptosis in premalignant lesions. Our results also provide additional evidence that BCAC are premalignant lesions in colon carcinogenesis in rodents.
Keywords: Apoptosis, ‐Catenin‐accumulated crypts, Aberrant crypt foci, Sulindac, Chemo‐prevention
Full Text
The Full Text of this article is available as a PDF (59.7 KB).
REFERENCES
- 1.Greenlee , R. T. , Murray , T. , Bolden , S. and Wingo , P. A.Cancer statistics, 2000 . CA Cancer J. Clin. , 50 , 7 – 33 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 2.Thun , M. J. , Namboodiri , M. M. and Heath , C. W.Jr. , Aspirin use and reduced risk of fatal colon cancer . N. Engl. J. Med. , 325 , 1593 – 1596 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 3.Giardiello , F. M. , Hamilton , S. R. , Krush , A. J. , Piantadosi , S. , Hylind , L. M. , Celano , P. , Booker , S. V. , Robinson , C. R. and Offerhaus , G. J.Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis . N. Engl. J. Med. , 328 , 1313 – 1316 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 4.Rao , C. V. , Rivenson , A. , Simi , B. , Zang , E. , Kelloff , G. , Steele , V. and Reddy , B. S.Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti‐inflammatory agent . Cancer Res. , 55 , 1464 – 1472 ( 1995. ). [PubMed] [Google Scholar]
- 5.Narisawa , T. , Satoh , M. , Sano , M. and Takahashi , T.Inhibition of initiation and promotion by N‐methylnitrosourea‐induced colon carcinogenesis in rats by non‐steroid antiinflammatory agent indomethacin . Carcinogenesis , 4 , 1225 – 1227 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 6.Boolbol , S. K. , Dannenberg , A. J. , Chadburn , A. , Martucci , C. , Guo , X. J. , Ramonetti , J. T. , Abreu‐Goris , M. , Newmark , H. L. , Lipkin , M. L. , DeCosse , J. J. and Bertagnolli , M. M.Cyclooxygenase‐2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis . Cancer Res. , 56 , 2556 – 2560 ( 1996. ). [PubMed] [Google Scholar]
- 7.Samaha , H. S. , Kelloff , G. J. , Steele , V. , Rao , C. V. and Reddy , B. S.Modulation of apoptosis by sulindac, curcumin, phenylethyl‐3‐methylcaffeate, and 6‐phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion . Cancer Res. , 57 , 1301 – 1305 ( 1997. ). [PubMed] [Google Scholar]
- 8.Marnett , L. J.Aspirin and the potential role of prostaglandins in colon cancer . Cancer Res. , 52 , 5575 – 5589 ( 1992. ). [PubMed] [Google Scholar]
- 9.Smith , W. L. , Meade , E. A. and DeWitt , D. L.Pharmacology of prostaglandin endoperoxide synthase isozymes‐1 and ‐2 . Ann. NY Acad. Sci. , 714 , 136 – 142 (Review) ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 10.Mahmoud , N. N. , Boolbol , S. K. , Dannenberg , A. J. , Mestre , J. R. , Bilinski , R. T. , Martucci , C. , Newmark , H. L. , Chadburn , A. and Bertagnolli , M. M.The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis . Carcinogenesis , 19 , 87 – 91 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 11.Brooks , P. M. and Day , R. O.Nonsteroidal antiinflammatory drugs—differences and similarities . N. Engl. J. Med. , 324 , 1716 – 1725 (Review) ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 12.Bird , R.Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings . Cancer Lett. , 37 , 147 – 151 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 13.Yamada , Y. , Yoshimi , N. , Hirose , Y. , Kawabata , K. , Matsunaga , K. , Shimizu , M. , Hara , A. and Mori , H.Frequent β‐catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis . Cancer Res. , 60 , 3323 – 3327 ( 2000. ). [PubMed] [Google Scholar]
- 14.Yamada , Y. , Yoshimi , N. , Hirose , Y. , Matsunaga , K. , Katayama , M. , Sakata , K. , Shimizu , M. , Kuno , T. and Mori , H.Sequential analysis of morphological and biological properties of β‐catenin‐accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis . Cancer Res. , 61 , 1874 – 1878 ( 2001. ). [PubMed] [Google Scholar]
- 15.Yamada , Y. , Yoshimi , N. , Hirose , Y. , Hara , A. , Shimizu , M. , Kuno , T. , Katayama , M. , Zheng , Q. and Mori , H.Suppression of occurrence and advancement of β‐catenin‐accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase‐2 inhibitor, celecoxib . Jpn. J. Cancer Res. , 92 , 617 – 623 ( 2001. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Greenwald , P. and Kelloff , G. J.The role of chemoprevention in cancer control . IARC Sci. Publ. , 139 , 13 – 22 ( 1996. ). [PubMed] [Google Scholar]
- 17.Tsujii , M. and DuBois , R. N.Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 . Cell , 83 , 493 – 501 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 18.Dive , C. and Hickman , J. A.Drug‐target interactions: only the first step in the commitment to a programmed cell death ? Br. J. Cancer , 64 , 192 – 196 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bedi , A. , Pasricha , P. J. , Akhtar , A. J. , Barber , J. P. , Bedi , G. C. , Giardiello , F. M. , Zehnbauer , B. A. , Hamilton , S. R. and Jones , R. J.Inhibition of apoptosis during development of colorectal cancer . Cancer Res. , 55 , 1811 – 1816 ( 1995. ). [PubMed] [Google Scholar]
- 20.Tanaka , T. , Takeuchi , T. , Nishikawa , A. , Takami , T. and Mori , H.Nucleolar organizer regions in hepatocarcinogenesis induced by N‐2‐fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry . Jpn. J. Cancer Res. , 80 , 1047 – 1051 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gavrieli , Y. , Sherman , Y. and Ben‐Sasson , S. A.Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation . J. Cell Biol. , 119 , 493 – 501 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Shiff , S. J. , Qiao , L. , Tsai , L. L. and Rigas , B.Sulindac sulfide, an aspirin‐like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT‐29 colon adenocarcinoma cells . J. Clin. Invest. , 96 , 491 – 503 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pasricha , P. J. , Bedi , A. , O'Connor , K. , Rashid , A. , Akhtar , A. J. , Zahurak , M. L. , Piantadosi , S. , Hamilton , S. R. and Giardiello , F. M.The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis . Gastroenterology , 109 , 994 – 998 ( 1995. ). [DOI] [PubMed] [Google Scholar]